Tim Oqueka

Tim Oqueka is a Senior Physician and Medical Specialist in Internal Medicine and Pneumology at the Center for Oncology within the II. Medical Clinic and Polyclinic at University Medical Center Hamburg-Eppendorf (UKE), part of the Faculty of Medicine. His clinical work focuses on complex pulmonary conditions with particular expertise in autoimmune lung diseases and interstitial lung disorders.

Dr. Oqueka's research spans multiple critical areas in pneumology including autoimmune pulmonary diseases, interstitial lung disease, pulmonary hypertension, and post-COVID complications. His work demonstrates strong interdisciplinary collaboration across rheumatology, immunology, and oncology departments, with emphasis on rare pulmonary conditions and treatment of complex comorbidities. Recent publications highlight innovative approaches to difficult clinical scenarios including biologic therapies for refractory autoimmune lung diseases and management of rare pulmonary complications.

Analysis of his publication record from 2019-2025 reveals a consistent focus on clinically challenging pulmonary conditions with particular expertise in autoimmune-related lung diseases (MDA5-dermatomyositis, sarcoidosis), vasculitic disorders (granulomatosis with polyangiitis), and complex pulmonary hypertension cases. His research methodology combines clinical case reports with larger observational studies, often translating basic science findings into practical clinical applications. The geographic focus appears primarily German with some international collaborations.

While specific awards aren't listed in the available information, Dr. Oqueka's substantial publication record in high-impact journals such as CHEST, RHEUMATOLOGY, and JOURNAL OF HEART AND LUNG TRANSPLANTATION indicates significant professional recognition. His work on daratumumab therapy for life-threatening vasculitis and management of rapidly progressive interstitial lung disease represents important clinical contributions to the field.

Dr. Oqueka maintains active clinical responsibilities alongside research, with particular focus on complex pneumology cases requiring multidisciplinary approaches. His work bridges the gap between oncology and pulmonary medicine, particularly in managing pulmonary complications in immunocompromised patients and those with autoimmune conditions. The Center for Oncology at UKE provides the institutional framework for his clinical and research activities, with access to advanced diagnostic and therapeutic resources.